文献速递心血管MR

心血管MRI定量评估心肌纤维化谱:猪组织病理学验证研究

Quantifying the Spectrum of Myocardial Fibrosis with Cardiovascular MRI: A Histopathologic Validation Study in Swine.
PubMed 文献 · Radiol Cardiothorac Imaging · 2026-01-01

本研究在18头雄性小型猪(16头慢性心肌梗死模型、2头健康对照)中,于2021年6月至2022年7月行心脏MRI(含电影、LGE、T1 mapping和ECV mapping),以组织病理学胶原容积分数(CVF)为参考,验证T1 mapping对轻至重度心肌纤维化的定量评估价值,并比较MOLLI与ShMOLLI两种T1 mapping技术。

要点

  • LGE、T1 mapping和ECV对重度纤维化(CVF≥30%)诊断性能均优(AUC 0.88-0.96)。
  • ShMOLLI序列ECV检测重度纤维化和MI的AUC均高于MOLLI序列ECV(0.96 vs 0.88,P=.03;0.93 vs 0.87,P=.045)。
  • 仅ShMOLLI序列T1和ECV能显著区分轻度纤维化远端心肌与健康心肌,LGE和MOLLI参数不能。

核心结论

  • 心脏MRI与组织学结果高度一致,可检测轻至重度心肌纤维化;所有技术均能准确识别重度纤维化,而T1 mapping(尤其是ShMOLLI序列的ECV)对低级别纤维化具有独特敏感性,凸显序列选择对精准心肌组织表征和临床试验设计的重要性。

研究设计与样本

  • 动物研究,纳入18头雄性小型猪(16头慢性心肌梗死模型、2头健康对照),于2021年6月至2022年7月行心脏MRI(电影、LGE、T1 mapping和ECV mapping),评估MOLLI和ShMOLLI两种T1 mapping技术;以三苯基四氮唑氯化物染色的病理心肌切片为参考标准,按胶原容积分数(CVF)将纤维化分为重度(CVF≥30%)、中度(CVF>15%-30%)和轻度(CVF 3%-15%)。

关键影像表现/征象

  • 病理切片按三苯基四氮唑氯化物染色分为梗死区、梗死周边区、远端区和健康区。
  • 在远端心肌轻度纤维化(CVF 8.81%)与健康心肌(CVF 2.21%)比较中,仅ShMOLLI序列T1和ShMOLLI序列ECV显示显著差异(P<.05)。
  • LGE范围和MOLLI序列参数在轻度纤维化远端心肌与健康心肌间未显示显著差异。

诊断标准与关键数值

  • 纤维化分级标准:重度CVF≥30%,中度CVF>15%-30%,轻度CVF 3%-15%。
  • 检测重度纤维化:LGE、T1 mapping和ECV的AUC范围为0.88-0.96。
  • 检测重度纤维化:ShMOLLI序列ECV的AUC为0.96,高于MOLLI序列ECV的0.88(P=.03)。
  • 检测MI:ShMOLLI序列ECV的AUC为0.93,高于MOLLI序列ECV的0.87(P=.045)。
  • 与组织学CVF相关性:ShMOLLI序列ECV r=0.90,MOLLI序列ECV r=0.84,ShMOLLI序列T1 r=0.74,MOLLI序列T1 r=0.77,LGE范围 r=0.74。

临床应用与阅片要点

  • 本研究表明ShMOLLI序列ECV与组织学CVF相关性最强(r=0.90),在评估重度纤维化和MI时AUC最高。
  • 对于轻度纤维化(CVF 8.81% vs 健康心肌CVF 2.21%),仅ShMOLLI序列T1和ECV显示显著差异,LGE和MOLLI参数未显示显著差异。
  • 作者指出序列选择对精准心肌组织表征和临床试验设计具有重要意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To histologically validate T1 mapping for quantitative assessment of mild-to-severe myocardial fibrosis in a swine model of chronic myocardial infarction (MI). Materials and Methods In this animal study conducted from June 2021 to July 2022, 18 male miniature swine (16 MI animals; two healthy control animals) underwent cardiac MRI, including cine imaging, late gadolinium enhancement (LGE) imaging, T1 mapping, and extracellular volume fraction (ECV) mapping. Two T1 mapping techniques, modified Look-Locker inversion recovery (MOLLI) and shortened MOLLI (ShMOLLI), were evaluated. Pathologic myocardial slices were categorized as infarcted, peri-infarct, remote, and healthy based on triphenyl tetrazolium chloride staining. Fibrosis was quantified using collagen volume fraction (CVF) and classified as severe (CVF, ≥30%), moderate (CVF, >15%-30%), or mild (CVF, 3%-15%). Associations between cardiac MRI parameters and CVF were assessed, and diagnostic performance in detecting myocardial fibrosis was evaluated using the area under the receiver operating characteristic curve (AUC). Results For detection of severe fibrosis, LGE, T1 mapping, and ECV all demonstrated excellent diagnostic performance (AUC range, 0.88-0.96). ECV using ShMOLLI showed significantly higher performance than ECV using MOLLI for detecting severe fibrosis (AUC, 0.96 vs 0.88; P = .03) and MI (AUC, 0.93 vs 0.87; P = .045), as well as the strongest correlation with histologic CVF (r = 0.90 for ECV with ShMOLLI, 0.84 for ECV with MOLLI, 0.74 for T1 with ShMOLLI, 0.77 for T1 with MOLLI, and 0.74 for LGE extent). In remote myocardium with mild fibrosis (CVF, 8.81%) compared with healthy myocardium (CVF, 2.21%), only T1 with ShMOLLI and ECV with ShMOLLI demonstrated significant differences (P < .05), whereas LGE and MOLLI-based parameters did not. Conclusion Cardiac MRI helped detect mild-to-severe myocardial fibrosis in close agreement with histologic findings. While all techniques helped accurately identify severe fibrosis, T1 mapping-particularly ECV using the ShMOLLI sequence-provided unique sensitivity for detecting low-grade fibrosis, underscoring the importance of sequence selection for precise myocardial tissue characterization and clinical trial design. Keywords: Myocardial Fibrosis, Heart, Histological Techniques, Magnetic Resonance Imaging, Swine Supplemental material is available for this article. © RSNA, 2026.

来源:Radiol Cardiothorac Imaging,查看原文。版权归原作者所有。

引用

  1. Zhang H, Chen C, Yang W, et al. Quantifying the Spectrum of Myocardial Fibrosis with Cardiovascular MRI: A Histopathologic Validation Study in Swine. Radiol Cardiothorac Imaging. 2026. PMID: 42059796. doi:10.1148/ryct.250476

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。